UY29625A1 - Uso de moduladores no esteroides de receptores de progesterona - Google Patents
Uso de moduladores no esteroides de receptores de progesteronaInfo
- Publication number
- UY29625A1 UY29625A1 UY29625A UY29625A UY29625A1 UY 29625 A1 UY29625 A1 UY 29625A1 UY 29625 A UY29625 A UY 29625A UY 29625 A UY29625 A UY 29625A UY 29625 A1 UY29625 A1 UY 29625A1
- Authority
- UY
- Uruguay
- Prior art keywords
- therapy
- prevention
- well
- progesterone receptors
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente invención se refiere a modulares no esteroides de receptores de progesterona de la fórmula general I, a su uso para preparar medicamentos, así como a las composiciones farmacéuticas que contienen estos compuestos. Los compuestos según la invención son apropiados para la terapia y la prevención de enfermedades ginecológicas tales como endometriosos, leiomiomas del útero, hemorragias disfuncionales y dismenorrea, así como para la terapia y la prevención de tumores dependientes de hormonas y para usar en el control de la fertilidad femenina y la terapia de reemplazo hormonal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005030293A DE102005030293A1 (de) | 2005-06-24 | 2005-06-24 | Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29625A1 true UY29625A1 (es) | 2007-01-31 |
Family
ID=37421093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29625A UY29625A1 (es) | 2005-06-24 | 2006-06-26 | Uso de moduladores no esteroides de receptores de progesterona |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060293317A1 (es) |
EP (1) | EP1895999A1 (es) |
JP (1) | JP2008543906A (es) |
AR (1) | AR054803A1 (es) |
CA (1) | CA2612161A1 (es) |
DE (1) | DE102005030293A1 (es) |
DO (1) | DOP2006000147A (es) |
GT (1) | GT200600270A (es) |
PE (1) | PE20070324A1 (es) |
TW (1) | TW200726461A (es) |
UY (1) | UY29625A1 (es) |
WO (1) | WO2007022824A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY30805A1 (es) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | Moduladores no esteroides de receptores de progesterona |
DE102007032800A1 (de) * | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
US20090099147A1 (en) * | 2007-07-10 | 2009-04-16 | Schwede Wolfgnag | Non-steroidal progesterone receptor modulators |
DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
EP2070909A1 (de) * | 2007-12-15 | 2009-06-17 | Bayer Schering Pharma AG | Nichtsteroidale Progesteronrezeptor-Modulatoren |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19723722A1 (de) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
US6245804B1 (en) * | 1997-05-30 | 2001-06-12 | Schering Aktiengesellschaft | Nonsteroidal gestagens |
WO2003059899A1 (en) * | 2002-01-14 | 2003-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
EP1344776A1 (en) * | 2002-03-11 | 2003-09-17 | Schering Aktiengesellschaft | 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders |
BRPI0412231A (pt) * | 2003-07-01 | 2006-08-22 | Schering Ag | derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação |
US20050090559A1 (en) * | 2003-07-01 | 2005-04-28 | Markus Berger | Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
-
2005
- 2005-06-24 DE DE102005030293A patent/DE102005030293A1/de not_active Withdrawn
-
2006
- 2006-06-22 CA CA002612161A patent/CA2612161A1/en not_active Abandoned
- 2006-06-22 WO PCT/EP2006/006265 patent/WO2007022824A1/en not_active Application Discontinuation
- 2006-06-22 JP JP2008517439A patent/JP2008543906A/ja active Pending
- 2006-06-22 EP EP06791526A patent/EP1895999A1/en not_active Withdrawn
- 2006-06-23 US US11/473,337 patent/US20060293317A1/en not_active Abandoned
- 2006-06-23 TW TW095122796A patent/TW200726461A/zh unknown
- 2006-06-26 PE PE2006000731A patent/PE20070324A1/es not_active Application Discontinuation
- 2006-06-26 DO DO2006000147A patent/DOP2006000147A/es unknown
- 2006-06-26 GT GT200600270A patent/GT200600270A/es unknown
- 2006-06-26 UY UY29625A patent/UY29625A1/es not_active Application Discontinuation
- 2006-06-27 AR ARP060102751A patent/AR054803A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20070324A1 (es) | 2007-04-12 |
EP1895999A1 (en) | 2008-03-12 |
DE102005030293A1 (de) | 2007-01-04 |
AR054803A1 (es) | 2007-07-18 |
US20060293317A1 (en) | 2006-12-28 |
CA2612161A1 (en) | 2007-03-01 |
GT200600270A (es) | 2008-05-05 |
DOP2006000147A (es) | 2006-12-31 |
TW200726461A (en) | 2007-07-16 |
WO2007022824A1 (en) | 2007-03-01 |
JP2008543906A (ja) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33470A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos | |
SV2010003580A (es) | Agonistas novedosos de los receptores de glucocorticoides | |
CR10875A (es) | Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides | |
AR051904A1 (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r) | |
CR10489A (es) | Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides | |
UY29626A1 (es) | Moduladores no esteroides de receptores de progesterona | |
CU20140064A7 (es) | Derivados de 6,7- dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos | |
UY29625A1 (es) | Uso de moduladores no esteroides de receptores de progesterona | |
CR20190379A (es) | Moduladores del receptor de estrógeno | |
ECSP078044A (es) | Moduladores no esteroides de receptor de progesterona | |
CR9627A (es) | Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof | |
UY31326A (es) | Compuestos de quinolina apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5-ht6 | |
UY30805A1 (es) | Moduladores no esteroides de receptores de progesterona | |
UY30815A1 (es) | Moduladores no esteroidales del receptor de progesterona | |
CL2008002027A1 (es) | Compuestos derivados de 16alfa-fluoro-estra-1,3,5(10)-trieno obeta-sustituido;composicion farmaceutica; y uso de los compuestos para tratar enfermedades inducidas por la deficiencia de estrogeno, infertilidad, sintomas peri y posmenopausicos, artritis reumatica, enfermedades intestinales inflamatorias, entre otras. | |
TH85615A (th) | สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์ | |
CU20090109A7 (es) | Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160831 |